Condition
MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
80%
4 trials in Phase 3/4
Results Transparency
150%
3 of 2 completed with results
Key Signals
3 with results50% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 4 (4)
Trial Status
Completed2
Terminated2
Unknown1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02572791Phase 4Completed
Staph Household Intervention for Eradication (SHINE)
NCT00966446Not ApplicableCompletedPrimary
Epidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the Community
NCT01786161Phase 4TerminatedPrimary
Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients
NCT01400308Phase 4TerminatedPrimary
Effectiveness of Two Protocols for Corporal Decolonization in Patients Colonized by Methicillin Resistant Staphylococcus Aureus (MRSA)
NCT01612052Phase 4UnknownPrimary
Vascular Surgical Antibiotic Prophylaxis Study (VSAPS 2)
Showing all 5 trials